The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
Open accessAbstract
Background: Parkinson’s disease (PD) is a common neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. Methods: In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood (PB) of PD patients. Ten PD patients were diagnosed according to brain bank criteria and underwent detailed clinical examination, magnetic resonance imaging, PB and CSF immune cell profiling by multiparameter flow cytometry, and cytokine and chemokine measurements by bead-based arrays. Thirteen healthy elderly volunteers served as control population. Results: The proportions of activated T-lymphocytes and nonclassical monocytes in the CSF were increased in patients with PD compared to the control group. In accordance, we found increased levels of the pro-inflammatory cytokines IL-2, IL-6 and TNFα and of the monocyte chemoattractant protein 1 (MCP-1) in the CSF of the included PD patients. Conclusions: Our data provide novel evidence for a response of the innate and adaptive immune system in the central nervous system of patients with PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated levels of cytokines (including IL1β, IL2, IL6, IFNγ, and TNFα) and CD4+ lymphocytes have been detected in both serum and CSF of PD patients.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [222]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,757
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
Tomlinson, C. L., Stowe, R. L., Patel, S., Rick, C., Gray, R. G., & Clarke, C. E. (2010) · Movement Disorders · doi:10.1002/mds.23429 · Cited by 4,310
Adams, J., Dinesh, K., Xiong, M., Tarolli, C. G., Sharma, S., Sheth, N., Aranyosi, A. J., Zhu, W. Y., Goldenthal, S. B., Biglan, K., et al. (2017) · Digital Biomarkers · doi:10.1159/000479018 · Cited by 3,190
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Cited by
Sorted by citations
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
Parkinson disease and the immune system - Associations, mechanisms and therapeutics
Tan, E.-K., Chao, Y.-X., West, A., Chan, L.-L., Poewe, W., & Jankovic, J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0344-4 · Cited by 457
B cells in autoimmune and neurodegenerative central nervous system diseases
Sabatino, J. J., Pröbstel, A., & Zamvil, S. S. (2019) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0233-2 · Cited by 361
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
Galiano-Landeira, J., Torra, A., Vila, M., & Bové, J. (2020) · Brain · doi:10.1093/brain/awaa269 · Cited by 267
Periphery and brain, innate and adaptive immunity in Parkinson’s disease
Harms, A. S., Ferreira, S. A., & Romero‐Ramos, M. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02268-5 · Cited by 291
Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
Araújo, B., Caridade-Silva, R., Soares-Guedes, C., Martins‐Macedo, J., Gomes, E. D., Monteiro, S., & Teixeira, F. G. (2022) · Cells · doi:10.3390/cells11182908 · Cited by 209
Inflammation, Infectious Triggers, and Parkinson's Disease
Caggiu, E., Arru, G., Hosseiniporgham, S., Niegowska, M., Sechi, G., Zarbo, I. R., & Sechi, L. A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00122 · Cited by 180
Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition
Ibarra-Gutiérrez, M. T., Serrano‐García, N., & Orozco‐Ibarra, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03193-8 · Cited by 187
Borrajo, A., Spuch, C., Penedo, M. A., Olivares, J. M., & Agís‐Balboa, R. C. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1814962 · Cited by 150
The immune system in Parkinson's disease: what we know so far
Roodveldt, C., Bernardino, L. I., Çakmak, Ö. Ö., Dragić, M., Fladmark, K. E., Ertan, S., Aktaş, B., Pita, C., Ciglar, L., Garraux, G., et al. (2024) · Brain · doi:10.1093/brain/awae177 · Cited by 151
Epstein-Barr Virus and Neurological Diseases
Zhang, N., Zuo, Y., Jiang, L., Peng, Y., Huang, X., & Zuo, L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.816098 · Cited by 140
Picca, A., Guerra, F., Calvani, R., Marini, F., Biancolillo, A., Landi, G., Beli, R., Landi, F., Bernabei, R., Bentivoglio, A. R., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020504 · Cited by 139
The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
Baizabal-Carvallo, J. F., & Alonso-Juarez, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.030 · Cited by 130
Wang, P., Yao, L., Luo, M., Zhou, W., Jin, X., Xu, Z., Shi, Y., Li, Y., Xu, C., Cheng, R., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00280-3 · Cited by 129
Patrick, K. L., Bell, S. L., Weindel, C. G., & Watson, R. O. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00138 · Cited by 110
Wijeyekoon, R., Kronenberg‐Versteeg, D., Scott, K. M., Hayat, S., Kuan, W., Evans, J., Breen, D. P., Cummins, G. A., Jones, J., Clatworthy, M. R., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.018 · Cited by 105
A Mendelian randomization study investigating the causal role of inflammation on Parkinson’s disease
Bottigliengo, D., Foco, L., Seibler, P., Klein, C., König, I. R., & Fabiola Del Greco, M. (2022) · Brain · doi:10.1093/brain/awac193 · Cited by 104
The immunology of Parkinson’s disease
Zhu, B., Yin, D., Zhao, H., & Zhang, L. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00947-3 · Cited by 108
Alterations in Blood Monocyte Functions in Parkinson's Disease
Nissen, S. K., Shrivastava, K., Schulte, C., Otzen, D. E., Goldeck, D., Berg, D., Møller, H. J., Maetzler, W., & Romero‐Ramos, M. (2019) · Movement Disorders · doi:10.1002/mds.27815 · Cited by 89
Kip, E., & Parr‐Brownlie, L. C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101618 · Cited by 89
Update on CSF Biomarkers in Parkinson’s Disease
Kwon, E. H., Tennagels, S., Gold, R., Gerwert, K. B., Beyer, L., & Tönges, L. (2022) · Biomolecules · doi:10.3390/biom12020329 · Cited by 85
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
Zimmermann, M., & Brockmann, K. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223277 · Cited by 76
Tönges, L., Buhmann, C., Klebe, S., Klucken, J., Kwon, E. H., Müller, T. H., Pedrosa, D. J., Schröter, N., Riederer, P. F., & Lingor, P. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02498-1 · Cited by 72
Armentero, M., Cerri, S., & Blandini, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00232 · Cited by 75
Wang, P., Luo, M., Zhou, W., Jin, X., Xu, Z., Yan, S., Li, Y., Xu, C., Cheng, R., Huang, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.814239 · Cited by 68
Neuroinflammation in Parkinson’s Disease: Triggers, Mechanisms, and Immunotherapies
Wang, T., Shi, C., Luo, H., Zheng, H., Fan, L., Tang, M., Su, Y., Yang, J., Mao, C., & Xu, Y. (2021) · The Neuroscientist · doi:10.1177/1073858421991066 · Cited by 69
T Lymphocytes in Parkinson’s Disease
Contaldi, E., Magistrelli, L., & Comi, C. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223152 · Cited by 65
The systemic immune response in Parkinson’s disease: focus on the peripheral immune component
Lauritsen, J., & Romero‐Ramos, M. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.005 · Cited by 66
Nissen, S. K., Farmen, K., Carstensen, M., Schulte, C., Goldeck, D., Brockmann, K., & Romero‐Ramos, M. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.01.005 · Cited by 62
Macrophage compartmentalization in the brain and cerebrospinal fluid system
Munro, D. A. D., Movahedi, K., & Priller, J. (2022) · Science Immunology · doi:10.1126/sciimmunol.abk0391 · Cited by 59
How should we be using biomarkers in trials of disease modification in Parkinson’s disease?
Vijiaratnam, N., & Foltynie, T. (2023) · Brain · doi:10.1093/brain/awad265 · Cited by 56
Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson’s disease
Sun, C., Zhao, Z., Yu, W., Mo, M., Song, C., Si, Y., & Liu, Y. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.10.105 · Cited by 55
Xiromerisiou, G., Marogianni, C., Lampropoulos, I. C., Dardiotis, E., Speletas, M. G., Ntavaroukas, P., Androutsopoulou, A., Kalala, F., Grigoriadis, N., & Papoutsopoulou, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010264 · Cited by 54
Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation
Rolfes, L., Schulte‐Mecklenbeck, A., Schreiber, S., Vielhaber, S., Herty, M., Marten, A., Pfeuffer, S., Ruck, T., Wiendl, H., Groß, C. C., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab157 · Cited by 56
Self-citationThe spatial landscape of glial pathology and T cell response in Parkinson’s disease substantia nigra
Ma, M., Paryani, F., Jakubiak, K. A., Xia, S., Antoku, S., Kannan, A., Lee, J., Madden, N., Kumar, S. S., Li, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62478-3 · Cited by 61
Greenland, J. C., Cutting, E., Kadyan, S., Bond, S. J., Chhabra, A., & Williams‐Gray, C. H. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040527 · Cited by 47
Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson’s disease
Su, Y., Shi, C., Wang, T., Liu, C., Yang, J., Zhang, S., Fan, L., Zheng, H., Li, X., Luo, H., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11258-w · Cited by 38
The Challenge of Disease-Modifying Therapies in Parkinson’s Disease: Role of CSF Biomarkers
Paoletti, F. P., Gaetani, L., & Parnetti, L. (2020) · Biomolecules · doi:10.3390/biom10020335 · Cited by 38
Angelopoulou, E., Paudel, Y. N., Villa, C., Shaikh, M. F., & Piperi, C. (2020) · Biology · doi:10.3390/biology9040086 · Cited by 40
Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight
Forloni, G., Vitola, P. L., Cerovic, M., & Balducci, C. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.11.001 · Cited by 41
Extracellular alpha-synuclein: Sensors, receptors, and responses
Domingues, R., Sant’Anna, R., da Fonseca, A. C. C., Robbs, B. K., Foguel, D., & Outeiro, T. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105696 · Cited by 38
Immune-related biomarkers for Parkinson's disease
Abdi, I. Y., Ghanem, S. S., & El‐Agnaf, O. M. A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105771 · Cited by 38
Santaella, A., Kuiperij, H. B., van Rumund, A., Esselink, R. A. J., van Gool, A. J., Bloem, B. R., & Verbeek, M. M. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-00124-z · Cited by 35
Impact of sex on neuroimmune contributions to Parkinson’s disease
Bourque, M., Morissette, M., Soulet, D., & Paolo, T. D. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110668 · Cited by 36
Seo, J., Park, J., Kim, K., Won, J., Yeo, H.-G., Jin, Y. B., Koo, B., Lim, K. S., Jeong, K.-J., Kang, P., et al. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.01.043 · Cited by 33
Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stress
Stevenson, T. J., Johnson, R. H., Savistchenko, J., Rustenhoven, J., Woolf, Z., Smyth, L. C. D., Murray, H. C., Faull, R. L. M., Correia, J. A., Schweder, P. M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-20261-0 · Cited by 34
Specificity of Adaptive Immune Responses in Central Nervous System Health, Aging and Diseases
Rickenbach, C., & Gericke, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.806260 · Cited by 33
Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
Gundersen, V. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.580311 · Cited by 33
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
Lai, T. T., Kim, Y. J., Ma, H.-I., & Kim, Y. E. (2022) · Journal of Movement Disorders · doi:10.14802/jmd.21078 · Cited by 32
Ulhaq, Z. S., & Garcia, C. P. (2020) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00056-6 · Cited by 28
Zhou, C., Zhou, X., He, D. N., Li, Z., Xie, X., & Ren, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01329 · Cited by 27
New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease
Tan, J. S. Y., Chao, Y., Rötzschke, O., & Tan, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239302 · Cited by 27
New Insights and Implications of Natural Killer Cells in Parkinson’s Disease
Menees, K. B., & Lee, J. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223212 · Cited by 26
Age-Related Adaptive Immune Changes in Parkinson’s Disease
Kouli, A., & Williams-Gray, C. H. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-223228 · Cited by 20
The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease
Sim, K.-Y., Im, K. C., & Park, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155295 · Cited by 24
Identification of Immune-Related Hub Genes in Parkinson’s Disease
Chen, L., Wang, Y., Huang, J., Hu, B., & Huang, W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.914645 · Cited by 25
Research progress in the early diagnosis of Parkinson’s disease
Xie, L., & Hu, L. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06316-0 · Cited by 23
Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond
Garmendia, J. V., Sanctis, C. V. D., Das, V., Annadurai, N., Hajdúch, M., & Sanctis, J. B. D. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231017141636 · Cited by 27
Ketotherapeutics for neurodegenerative diseases
Norwitz, N. G., Gilbert‐Jaramillo, J., Clarke, K., & Soto-Mota, A. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.003 · Cited by 24
Hull, A. J., Atilano, M. L., Gergi, L., & Kinghorn, K. J. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0381 · Cited by 24
Blood Biomarkers in Patients with Parkinson’s Disease: A Review in Context of Anesthetic Care
Joo, J. D., Jeong, J., & Park, H. J. (2023) · Diagnostics · doi:10.3390/diagnostics13040693 · Cited by 22
Netzahualcoyotzi, C., Santillán‐Cigales, J. J., Adalid-Peralta, L. V., & Velasco, I. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16106 · Cited by 24
Myelin-reactive B cells exacerbate CD4+ T cell-driven CNS autoimmunity in an IL-23-dependent manner
Fazazi, M. R., Doss, P. M. I. A., Pereira, R., Fudge, N., Regmi, A., Joly-Beauparlant, C., Akbar, I., Yeola, A. P., Mailhot, B., Baillargeon, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49259-0 · Cited by 21
Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?
Furgiuele, A., Pereira, F. C., Martini, S., Marino, F., & Cosentino, M. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1469 · Cited by 23
Differentiation and regulation of CD4+ T cell subsets in Parkinson’s disease
Sun, X., Gu, R., & Bai, J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05402-0 · Cited by 23
Aerobic exercise-induced changes in fluid biomarkers in Parkinson’s disease
Luthra, N., Mehta, N., Munoz, M. J., Fantuzzi, G., Lamotte, G. J., Haus, J. M., McFarland, N. R., Tansey, M. G., González-Latapí, P., Caraveo, G., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01042-8 · Cited by 24
Abnormal subpopulations of monocytes in the cerebrospinal fluid of patients with Parkinson's disease
Pillny, C., Nitsch, L., Proske-Schmitz, S., Sharma, A., & Wüllner, U. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.02.017 · Cited by 19
Huang, Y., Liu, H., Hu, J., Han, C., Zhong, Z., Luo, W., Zhang, Y., & Ling, F. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.686066 · Cited by 20
Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers
Farotti, L., Paoletti, F. P., Simoni, S., & Parnetti, L. (2020) · Biomarker Insights · doi:10.1177/1177271920964077 · Cited by 19
Sirkis, D. W., Solsberg, C. W., Johnson, T. P., Bonham, L. W., Sturm, V. E., Lee, S. E., Rankin, K. P., Rosen, H. J., Boxer, A. L., Seeley, W. W., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01205-3 · Cited by 19
Gao, M., Wang, X., Su, S., Feng, W., Lai, Y., Huang, K., Cao, D., & Wang, Q. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01595 · Cited by 18
Hörner, M., Groh, J., Klein, D., Ilg, W., Schöls, L. J., Santos, S. D., Bergmann, A., Klebe, S., Cauhapé, M., Branchu, J., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114119 · Cited by 15
Thomas, R., Connolly, K. J., Brekk, O. R., Hinrich, A. J., Hastings, M. L., Ole Isacson, A., & Hallett, P. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-41240-z · Cited by 16
Wang, Y., Shi, X., Yin, Y., Yang, F., Zhang, Y., He, X., Wen, D., Li, B., & Ma, K. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04197-2 · Cited by 16
Greenland, J. C., Holbrook, J. A., Kahanawita, L., Camacho, M., Fryer, T. D., Hong, Y. T., & Williams‐Gray, C. H. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.028 · Cited by 16
Early diagnosis of Parkinson’s disease: biomarker study
Li, J., Zhang, M., Yu, C.-Q., Xue, M., & Hu, P. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1495769 · Cited by 16
The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson’s Disease
Guedes, B. F. S., Cardoso, S. M., & Esteves, A. R. (2023) · Biomedicines · doi:10.3390/biomedicines11051349 · Cited by 16
Sadowski, K. A., Zając, W., Milanowski, Ł., Koziorowski, D., & Figura, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147741 · Cited by 22
Inflammation and heterogeneity in synucleinopathies
Freuchet, A., Pinçon, A., Sette, A., & Arlehamn, C. S. L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1432342 · Cited by 15
Yeh, F., Chen, H., Chou, Y., Lin, C., Kao, C., Lo, H., Liu, F., & Yang, T.-Y. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02629-w · Cited by 15
Boosting peripheral immunity to fight neurodegeneration in the brain
Schwartz, M., & Colaiuta, S. P. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.08.002 · Cited by 15
Zhang, P., Zhao, L., Li, H., Shen, J., Li, H., & Xing, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1083928 · Cited by 12
TREM-1 mediates interaction between substantia nigra microglia and peripheral neutrophils
Shen, T., Cui, G., Chen, H., Huang, L. Y., Song, W., Zu, J., Zhang, W., Xu, C., Dong, L., & Zhang, Y. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385843 · Cited by 12
Future Prospects in Parkinson’s Disease Diagnosis and Treatment
Öksüz, N., Öztürk, Ş., & Doğu, O. (2022) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.28169 · Cited by 11
Srivastava, P., Nishiyama, S., Zhou, F., Lin, S., Srivastava, A., Su, C., Xu, Y., Peng, W., Levy, M., Schwarzschild, M. A., et al. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10094-7 · Cited by 11
Hargarten, J. C., Anjum, S. H., Ssebambulidde, K., Park, Y., Vaughan, M. J., Scott, T. L., Hammoud, D. A., Billioux, B. J., & Williamson, P. R. (2023) · Journal of Clinical Immunology · doi:10.1007/s10875-023-01592-7 · Cited by 10
Cerebrospinal fluid protein biomarkers in Parkinson's disease
Faizan, M., Sachan, N., Verma, O., Sarkar, A., Rawat, N., & Singh, M. P. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.117848 · Cited by 9
Gonçalves, M., Rodrigues‐Santos, P., Januário, C., Cosentino, M., & Pereira, F. C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112062 · Cited by 9
T Lymphocytes and Their Potential Role in Dementia with Lewy Bodies
Amin, J., Gee, C., Stowell, K., Coulthard, D., & Boche, D. (2023) · Cells · doi:10.3390/cells12182283 · Cited by 10
Hargarten, J. C., Ssebambulidde, K., Anjum, S. H., Vaughan, M. J., Xu, J., Ganguly, A., Dulek, B., Otaizo-Carrasquero, F. A., Song, B., Tao, S., et al. (2025) · Science Advances · doi:10.1126/sciadv.adi9885 · Cited by 9
Recinto, S. J., Kazanova, A., Liu, L., Cordeiro, B., Premachandran, S., Bessaiah, H., Allot, A., Afanasiev, E., Mukherjee, S., Pei, J., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00945-w · Cited by 11
Multimodal markers of immune activation predict cognitive outcomes in Parkinson’s disease
Scott, K. M., Spindler, L. R. B., Peattie, A. R. D., Kouli, A., Fryer, T. D., Hong, Y. T., Camacho, M., Solim, I. H., Kahanawita, L., & Williams‐Gray, C. H. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.05.020 · Cited by 10
Single-cell transcriptomics for immune profiling of cerebrospinal fluid in neurological diseases
Ramos-Vicente, D., Monterosso, P., de Fàbregues, O., Roch, G., Vila, M., & Bové, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1599303 · Cited by 8
Distinct responses of human peripheral blood cells to different misfolded protein oligomers
Leal‐Lasarte, M., Mannini, B., Chiti, F., Vendruscolo, M., Dobson, C. M., Roodveldt, C., & Pozo, D. (2021) · Immunology · doi:10.1111/imm.13377 · Cited by 8
Muñoz‐Delgado, L., Williams‐Gray, C. H., Garraux, G., Clemente, D., Çakmak, Ö. Ö., Greenland, J. C., Figueira, I., Machín-Díaz, I., Pirovano, E., di Flora, A., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01146-1 · Cited by 7
Anti-Inflammatory Effect of Traditional Chinese Medicine on the Concept of Mind-Body Interface
Tsai, S.-T., Nithiyanantham, S., Satyanarayanan, S. K., & Su, K. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_19 · Cited by 7
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation
Bassi, M. S., Gilio, L., Galifi, G., Buttari, F., Dolcetti, E., Bruno, A., Belli, L., Modugno, N., Furlan, R., Finardi, A., et al. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106071 · Cited by 6
Zeng, Y., Guo, R., Cao, S., Liu, C., & Yang, H. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106953 · Cited by 7
Chen, H., Xie, W., Chang, Z., Zhang, J., & Xie, D. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00481.2023 · Cited by 5
Yang, J., Cui, Y., Zhao, J., Tang, S., Wang, A., Wang, J., Chen, Y., Luo, J., Wang, G., Yan, J., et al. (2024) · Brain and Behavior · doi:10.1002/brb3.3648 · Cited by 4
Metadata
- Authors
- Schröder, J. B., Pawlowski, M., Meyer zu Hörste, G., Gross, C. C., Wiendl, H., Meuth, S. G., Ruck, T., & Warnecke, T.
- Affiliations
- University Hospital Münster (DE)
- Corresponding author
- Warnecke, Tobias
- ORCID
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2018-12-18
- Volume
- 9
- Pages
- 1081-1081
- ISSN
- 1664-2295 (ISSN-L)
- PMC
- PMC6305582
- OpenAlex
- W2903888966
- Cited by
- 134
- References
- 46
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 22 · 2023: 20 · 2022: 25 · 2021: 10 · 2020: 22 · 2019: 7
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Frontiers in Neurology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- URN:NBN Resolver for Germany & Switzerland (German National Library) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, cerebrospinal fluid, immune cell activation, T cells, non-classical monocytes, inflammatory cytokines, interleukin-6, TNF-α, interleukin-2, MCP-1, chemokines, innate and adaptive immunity, neuroinflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review